Sangamo Therapeutics, a biotech company developing treatment for genetic conditions, announced that it is laying off 162 employees, or 40% of the company's U.S. workforce, as the company looks to restructure and focus on the creation of neurological treatments.
Innovation
Oakland, Calif.-based Kaiser Permanente has been developing artificial intelligence tools that track patient deterioration for more than a decade, The Washington Post reported Nov. 7.
Some hospital leaders are optimistic that artificial intelligence could liberate their clinicians from hours of administrative work and return them to the bedside.
Cleveland Clinic is accelerating its pace with quantum computing as it looks to explore how quantum computing can optimize healthcare's complex systems and drug discovery as well as see if it can provide more accuracy than AI models.
Despite the souring digital health venture market, large health systems with investment arms, such as Cleveland Clinic and Memorial Hermann, have still been active in financing innovative medtech companies.
Advertisement
Orlando (Fla.) Health said it became Walmart's first health system partner to provide patients with care not offered at the retailer's clinics and because both organizations share a goal of expanding access to healthcare.
Two distinct — yet similar — approaches for buying health systems emerged in 2023.
As the newly appointed chief AI officer of Phoenix-based Mayo Clinic Arizona, Bhavik Patel, MD, described his new role as the opportunity to be at the forefront of long-overdue disruptive innovation.
Kaiser Permanente Ventures, the investment arm of Oakland, Calif.-based Kaiser Permanente, co-led a $42.5 million financing round for women's medtech company Gynesonics.
Cleveland Clinic has introduced the Quantum Innovation Catalyzer Program, an initiative designed to foster competition among startup companies interested in investigating quantum computing's potential applications in healthcare and life sciences.